• News
  • Finance

Daily Digest

Encore Capital Group Inc announced it sold $100 million in aggregate principal amount of its 3 percent Convertible Senior Notes due 2017 in a private placement transaction, and Isis Pharmaceuticals Inc announced a strategic alliance with AstraZeneca for the discovery and development of novel generation antisense therapeutics to treat five types of cancer, according to company announcements, SEC filings and Bloomberg News.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!